Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
NCT03147638
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Heparin-induced Thrombocytopenia
Interventions
DRUG:
Warfarin, NOAC
Sponsor
Marshall University